# Hexium

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hexium

- Headquarters: Austin, US
- Website: www.hexium.us
- Total disclosed funding: $8M
- Latest round: Seed (Jul 15, 2024)
- Investors on record: 6

## About

Hexium is a technology-driven company specializing in isotope enrichment processes, particularly focusing on lithium, to enhance applications in the nuclear sector and related industries. Hexium, founded in 2023 by co-founders Martin Griswold and Jacob Peterson in Austin, US, specializes in isotope enrichment technology. The company has completed 2 deals to date, with its most recent transaction occurring on April 16, 2025. Hexium has raised a total of USD 8.00 mn in funding through its latest round, an Unspecified Round. Hexium specializes in innovative isotope enrichment technology aimed at advancing the nuclear sector, with a primary focus on lithium. The company's core offering employs Laser Isotope Separation (AVLIS) technology, utilizing precise laser wavelengths to selectively ionize specific isotopes from a vaporized metal stream. This method allows for the efficient separation of enriched isotopes, targeting high-purity outputs while avoiding the complexities associated with traditional mechanical and chemical separation methods. The enriched isotopes produced are intended for various applications, including clean energy generation, nuclear medicine, and advanced industrial uses, catering to a diverse clientele that spans industries reliant on isotopes. Geographically, Hexium’s products serve markets worldwide, with particular emphasis on regions experiencing bottlenecks in isotope supply, positioning the company as a vital player in both domestic and global nuclear ecosystems. Hexium operates on a transaction structure primarily focused on B2B sales, supplying enriched isotopes to industrial, medical, and energy sector clients. The company engages in direct partnerships with organizations that require high-quality isotopes, facilitating tailored agreements based on specific needs and project requirements. Transactions typically involve long-term supply contracts that ensure consistent delivery of the enriched isotopes, fundamental for various applications in clean energy and nuclear medicine. Pricing structures for these contracts are established based on the value and purity of the isotopes provided, with flagship products including highly enriched lithium isotopes. Hexium’s strategic approach to optimizing production and maintaining low operational costs reinforces its competitive position within the isotope market, fostering stable revenue streams from its diverse client base. In April 2025, Hexium is set to announce the launch of new products designed to expand its isotope offerings. The company plans to enter new geographic markets, specifically targeting regions in Europe and Asia by late 2025. The recent funding of USD 8.00 mn will support these initiatives by enhancing their production capabilities and facilitating entry into these new markets.

## Funding rounds

- Seed, Jul 15, 2024, $8M — R7 Partners, Refactor Capital, MaC Venture Capital, Julian Capital, Overture, Humba Ventures

## Investors

- R7 Partners (https://capitalatlas.ai/funds/r7-partners) — Seed
- Refactor Capital (https://capitalatlas.ai/funds/refactor-capital) — Seed
- MaC Venture Capital (https://capitalatlas.ai/funds/mac-venture-capital) — Seed
- Julian Capital (https://capitalatlas.ai/funds/julian-capital) — Seed
- Overture (https://capitalatlas.ai/funds/overture) — Seed
- Humba Ventures — Seed